Clinical trial
A Randomized, Double-blinded, Placebo-controlled, Parallel, Multicenter, Phase 2b Study to Evaluate the Efficacy and Safety of CVI-HBV-002 in Patients With Chronic Hepatitis B Taking Tenofovir
NCT04289987 is registered in ClinicalTrials.gov with Aribio Lab Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blinded, Placebo-controlled, Parallel, Multicenter, Phase 2b Study to Evaluate the Efficacy and Safety of CVI-HBV-002 in Patients With Chronic Hepatitis B Taking Tenofovir
- Lead sponsor
- Aribio Lab Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 19, 2020
- Completion date
- December 4, 2023
- Enrollment
- 134 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.